Articles
10 articles available
Filko Prugo
(Ropes & Gray LLP)
,
Charlotte Jacobsen
(Gibson, Dunn & Crutcher LLP)
,
Matthew Rizzolo
,
Henry Huang
(Ropes & Gray LLP)
January 29, 2019
For manufacturers of biologics and biosimilars facing potential patent litigation in the U.S., the Biologics Price Competition and Innovation Act (BPCIA) imposes a complex statutory scheme that…